Medication adherence halves COPD patients’ hospitalisation risk
In a study of claims data for 13,557 COPD patients in Switzerland, patients with high medication adherence (daily medication reserve of 80% to 100%) are 51% less likely to incur exacerbation, than patients with the lowest medication adherence (daily medication reserve of 0% to 20%). The study shows that medication adherence varies strongly among Swiss […]
Dr Yassir Javaid, GP advisor to Helicon Health
Helicon Health is delighted to announce that Dr Yassir Javaid will join the Helicon Health team of special advisors. Dr Javaid is a GP with a specialist interest in cardiology. Dr Javaid qualified from Cambridge University and completed his VTS training in Northampton. He has a specialist interest in cardiology and echocardiography and was a […]
Helicon Health speaks up for COPD
Source: https://www.politico.eu/sponsored-content/speaking-up-for-copd-a-global-call-for-policy-action/ Helicon Health is supporting Speak Up for COPD. Did you know – someone dies every 10 seconds from COPD? COPD, or chronic obstructive pulmonary disease, is the third largest cause of death, but no one talks about it. As a result, it is under-prioritised, underfunded and undertreated. Helicon Health is supporting The Speak […]
Helicon Health Partner to Accelerate New Technology Solutions for Children & Young People
The Helicon Health team are delighted to announce our role as Delivery and Go to Market partners for a new HealthTech accelerator programme in partnership with the world class National Centre for Children’s Health Technology, located in Sheffield. The National Centre for Child Health Technology will be focused specifically on developing and deploying new, internationally […]
Helicon Health sponsors Child Health Technology Conference 2023 for the second year running
Helicon Health is sponsoring CHT2023 (Child Health Technology Conference) for the second year running and are very pleased to be supporting such an excellent and important event. CHT2023 brings together thought leaders, medical practitioners, researchers, developers, delivery partners and investors from around the world. CHT2023 is suitable for professionals with an interest in child health […]
Digital Clinical Trials: Presentation of Smart Technologies and Wearables PoC – potential for NHS Service improvements
The Helicon Team were delighted to be invited to present the results of two major studies conducted on behalf of NHS Lincolnshire ICB evaluating the potential impact of smart technologies and wearables. The workshop was Chaired by Jimmy Pryke-Walker, Head of Digital Health at Lincolnshire Community Health Services NHS Trust. Dr Majid Akram, Cardiovascular Lead […]
Assessing the Economic Impact of Respiratory Diseases
Lung disease exacts a substantial economic toll on the United Kingdom, affecting individuals, families, healthcare systems, and society at large. Understanding the economic impact of lung diseases in the UK is crucial for addressing these issues effectively. Here is an overview of the costs associated with lung disease in the UK: Direct Healthcare Costs: Primary […]
Helicon Health is 11!
Please join us in celebrating 11 years of hugely productive operations. This last year has seen several developments towards our mission of delivering healthcare virtually – culminating in one of the largest evidential programmes of its kind with potentially game changing implications for health and care delivery – as the NHS experiences a tsunami of […]
Helicon appoints Sander ten Veldhuijs as Director of Operations
LONDON, February 8th 2023 / Helicon Health Limited (“Helicon”), the leading provider of technologies and expertise for delivering healthcare virtually, is pleased to announce the appointment of a Director of Operations, Sander ten Veldhuijs. Sander is responsible for maintaining and elevating organisational efficiency as Helicon continues to scale. Sander will oversee key business functions including […]
Helicon CEO to Present to The Royal Society of Medicine
Helicon Health CEO – Spotlight on Digital Therapeutics – Royal Society of Medicine – Wed. 18th January 2023 Digital Therapeutics (DTx) have been evolving for over a decade and promise to supplement or potentially replace some clinical therapies. Their potential value in facilitating significant benefits, such as meeting unmet patient needs, self-management and shared care […]
